InvestorsHub Logo
Followers 261
Posts 19732
Boards Moderated 0
Alias Born 10/03/2004

Re: TheDane post# 269053

Monday, 07/29/2019 10:41:37 AM

Monday, July 29, 2019 10:41:37 AM

Post# of 402878
The UC/Crohns trial will most likely be similar to the previous IBD trial—proof of concept, small trial, about 20 patients. The cost could range from $3 million to $7 million. That would include drug preparations and pharmacy start up as well as paying for PI, Coordinator and clinical space, plus all testing including multiple xoscopy exams, blood tests and MRIs. One can speculate on the term ”substantial” from there.

* Never borrow to invest.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News